|
|
|
Insider
Information: |
Maddon Paul J |
Relationship: |
Director |
City: |
Tarrytown |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
909,891 |
|
Indirect Shares
|
1,000 |
|
|
Direct
Value |
$3,730,553 |
|
|
Indirect Value
|
$4,100 |
|
|
Total
Shares |
910,891 |
|
|
Total
Value |
$3,734,653 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Progenics Pharmaceuticals Inc |
PGNX |
Director |
2010-12-01 |
909,891 |
2005-04-01 |
1,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
123 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PGNX |
Progenics Pharmaceuticals... |
Director |
|
2010-12-01 |
4/A |
AB |
$4.90 |
$24,500 |
D/D |
5,000 |
909,891 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2010-12-01 |
4 |
AB |
$4.90 |
$24,500 |
D/D |
5,000 |
854,057 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chairman of the Board and CEO |
|
2003-10-01 |
4 |
A |
$16.81 |
$99,095 |
D/D |
5,895 |
579,140 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
CEO & CSO |
|
2005-06-21 |
4 |
S |
$20.00 |
$125,163 |
D/D |
(6,250) |
599,303 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-06-15 |
4 |
AS |
$22.00 |
$215,054 |
D/D |
(9,774) |
604,829 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-06-15 |
4 |
OE |
$5.33 |
$52,095 |
D/D |
9,774 |
608,603 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
officerTitle |
|
2006-02-01 |
4 |
OE |
$5.33 |
$53,300 |
D/D |
10,000 |
596,615 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
officerTitle |
|
2006-02-01 |
4 |
S |
$27.73 |
$277,270 |
D/D |
(10,000) |
586,615 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-02-15 |
4 |
AS |
$27.17 |
$271,680 |
D/D |
(10,000) |
586,615 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-02-15 |
4 |
OE |
$5.33 |
$53,300 |
D/D |
10,000 |
596,615 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-03-01 |
4 |
AS |
$29.02 |
$290,210 |
D/D |
(10,000) |
586,615 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-03-01 |
4 |
OE |
$5.33 |
$53,300 |
D/D |
10,000 |
596,615 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-03-15 |
4 |
OE |
$5.33 |
$53,300 |
D/D |
10,000 |
614,695 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-03-15 |
4 |
AS |
$27.00 |
$270,040 |
D/D |
(10,000) |
604,695 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-04-03 |
4 |
AS |
$25.52 |
$258,643 |
D/D |
(10,000) |
604,829 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-04-17 |
4 |
OE |
$5.33 |
$53,300 |
D/D |
10,000 |
607,329 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-04-17 |
4 |
AS |
$24.78 |
$250,025 |
D/D |
(10,000) |
604,829 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-05-01 |
4 |
AS |
$23.52 |
$235,200 |
D/D |
(10,000) |
604,829 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-05-01 |
4 |
OE |
$5.33 |
$53,300 |
D/D |
10,000 |
614,829 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-05-15 |
4 |
AS |
$20.91 |
$209,090 |
D/D |
(10,000) |
604,829 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-05-15 |
4 |
OE |
$5.33 |
$53,300 |
D/D |
10,000 |
614,829 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-06-01 |
4 |
AS |
$21.79 |
$218,152 |
D/D |
(10,000) |
604,829 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-06-01 |
4 |
OE |
$5.33 |
$53,300 |
D/D |
10,000 |
607,829 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-04-03 |
4 |
OE |
$5.33 |
$85,736 |
D/D |
11,490 |
607,329 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
Chief Executive Officer/CSO |
|
2006-07-03 |
4 |
AS |
$23.84 |
$286,044 |
D/D |
(12,000) |
592,492 |
0 |
- |
|
123 Records found
|
|
Page 2 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|